Tufts-CEVR HEOR Leaders Survey

How will HEOR leaders respond to recent policy changes? A survey from Tufts and the Center for the Evaluation of Value and Risk in Health (CEVR) provides the answer. About 2/3 of the n=57 respondents were Head of their HEOR department and the remaining 1/3 had some other senior level HEOR role. Three key topic…

Read More

Healthcare Economist Weekly Reader

FDA accepts 1st In Silico Drug Development Tool.Why GLP-1’s got more affordable.BALANCE after CMS GLP-1 decision.How to socialize scientific ideas in the age of AI.Mapping the Ebola outbreak.1985-2023: MIT’s faculty grew 9%…Administrative staff grew 189%

Read More

On the importance of innovation and entrepreneurship

“I will maintain that there is no comparably important question in economics, because this is the question of human progress. This is the question of human wellbeing over millennia. Everything else about resource allocation, about policy, about macro…everything else is a footnote to this larger question of how new things come into being and how…

Read More

How LG Is Moving Into Clinical Workflows

As it deepens its push into healthcare, LG is developing more tools and workstations aimed at supporting clinical workflows. National sales leader Jim Salamon said the company’s innovations are designed around clinician needs, such as the desire for more lifelike color representation and lightweight displays that can be set up easily for home use. The…

Read More